Abstract

Piper guineense is a food and medicinal plant commonly used to treat infectious diseases in West-African traditional medicine. In a bid to identify new antibacterial compounds due to bacterial resistance to antibiotics, twelve extracts of P. guineense fruits and leaves, obtained by sequential extraction, as well as the piperine and piperlongumine commercial compounds were evaluated for antibacterial activity against human pathogenic bacteria. HPLC-DAD and UHPLC/Q-TOF MS analysis were conducted to characterize and identify the compounds present in the extracts with promising antibacterial activity. The extracts, with the exception of the hot water decoctions and macerations, contained piperamide alkaloids as their main constituents. Piperine, dihydropiperine, piperylin, dihydropiperylin or piperlonguminine, dihydropiperlonguminine, wisanine, dihydrowisanine and derivatives of piperine and piperidine were identified in a hexane extract of the leaf. In addition, some new piperamide alkaloids were identified, such as a piperine and a piperidine alkaloid derivative and two unknown piperamide alkaloids. To the best of our knowledge, there are no piperamides reported in the literature with similar UVλ absorption maxima and masses. A piperamide alkaloid-rich hexane leaf extract recorded the lowest MIC of 19 µg/mL against Sarcina sp. and gave promising growth inhibitory effects against S. aureus and E. aerogenes as well, inhibiting the growth of both bacteria with a MIC of 78 µg/mL. Moreover, this is the first report of the antibacterial activity of P. guineense extracts against Sarcina sp. and E. aerogenes. Marked growth inhibition was also obtained for chloroform extracts of the leaves and fruits against P. aeruginosa with a MIC value of 78 µg/mL. Piperine and piperlongumine were active against E. aerogenes, S. aureus, E. coli, S. enterica, P. mirabilis and B. cereus with MIC values ranging from 39–1250 µg/mL. Notably, the water extracts, which were almost devoid of piperamide alkaloids, were not active against the bacterial strains. Our results demonstrate that P. guineense contains antibacterial alkaloids that could be relevant for the discovery of new natural antibiotics.

Highlights

  • Bacterial infections, resulting from bacterial contamination of food and water as well as from wound and post-operative infections are currently a menace in Sub-Saharan Africa [1]

  • The increasing microbial resistance to antibiotics has led to the search for new antibacterial agents from medicinal plants [2] and medicinal plants such as Piper guineense and Xylopia aethiopica, which are used in the treatment of bacterial infections in West African traditional medicine, could be good sources for these compounds

  • Our result demonstrates that chloroform extracts of the leaves of P. guineense containa high variety and concentration of piperamide alkaloids and other non-polar compounds that may be explored as antibacterial agents, alone and in combinations with antibiotics, for multidrug-resistant bacteria

Read more

Summary

Introduction

Bacterial infections, resulting from bacterial contamination of food and water as well as from wound and post-operative infections are currently a menace in Sub-Saharan Africa [1]. The continuous increase in microbial resistance due to the gross misuse of antibiotics has led to a decline in the effectivity of antibiotic treatments. Antibiotics 2018, 7, 98 with good efficacy, few and mild adverse effects and low cost. The increasing microbial resistance to antibiotics has led to the search for new antibacterial agents from medicinal plants [2] and medicinal plants such as Piper guineense and Xylopia aethiopica, which are used in the treatment of bacterial infections in West African traditional medicine, could be good sources for these compounds. Based on numerous pharmacological studies, there is growing interest in medicinal plants as sources of antibacterial agents and adjuvants [3,4]. It has been established that plant-derived compounds and plant extracts are potential sources for new antibacterial drugs against multi-drug-resistant (MDR)

Objectives
Methods
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call